
Zensar Technologies Q2 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 4
Margin
Category 3
Fundraise
N/A
Order
Yes
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 4- The company aims to move up one performance quadrant every year, targeting top-quadrant status over a multi-year horizon. (Manish Tandon, Page 15)
- Sales headcount is considered adequate currently, but quality of sales performance is continuously monitored with counseling for underperformers. (Page 15)
- Order book stands strong at $194.8 million, indicating healthy deal wins and a strong sales pipeline. (Page 7)
- Growth driven mainly by farming existing clients and adding net new logos; non-top 20 clients are growing faster than top 20 clients. (Page 11)
- Healthcare vertical is seeing focused leadership and is expected to add growth opportunities. (Pages 7, 11)
- Large deals (>$5 million ACV) are in the pipeline but expected to be margin dilutive initially; company is preparing to invest for such deal wins. (Page 12, 15)
- Potential headwinds in Hitech vertical due to industry conditions may delay growth in that segment. (Page 7, 14)
- Overall, company expects continued sales acceleration, balanced by macroeconomic challenges and furlough impacts, with focus on long-term growth. (Pages 6, 14, 15)
See what Zensar Technologies management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Zensar Technologies management said on order book — free account, 30 seconds.
Capex plans
Yes- The company is focused on reinvesting margins back into the business to build capabilities, particularly in sales and leadership, with impact expected in Q3 and Q4 FY24.
- There is ongoing investment in capability building across technology areas such as Advanced Engineering, cloud-native capabilities, Experience Services, Oracle, SAP, and Salesforce.
- Investments are also planned to be calibrated to be ready for growth when the industry environment improves.
- No specific details on large capex or strategic investments are provided, but any margin over and above the 14-16% range is earmarked for reinvestment in the business.
- Investments are balanced with managing margins to stay within mid-teens range while supporting sales and capability building efforts.
- Investments include building sales force and leadership, with recent onboarding of Healthcare vertical leadership as part of domain expansion.
- The company is prepared to invest further if large deals are won, though such deals initially may not be margin accretive.
Track Zensar Technologies — get its next earnings analysis in your feed
How does Zensar Technologies rank vs peers in IT - Software?
Pro featureHow does Zensar Technologies rank in IT - Software?
Compare Zensar Technologies against every IT - Software company (Q2 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Zensar Technologies's management said in earlier quarters
Others in IT - Software this season
- Virtual Galaxy (Q2 FY27)
Q2 FY27 revenue from operations was ₹64.2 crore, up 59% sequentially (Page 4). Key investor presentation takeaways from Virtual Galaxy Infotech Ltd's Q2 FY27 in
- California Software Company (Q2 FY27)
For the quarter ended 30 September 2026, California Software Company Limited reported revenue from operations of ₹263.11 lakhs. Key results statement takeaways
- Delaplex (Q2 FY27)
Revenue from operations (Consolidated) for the half year ended September 30, 2026: ₹4,135.42 Lakhs, up from ₹3,717.75 Lakhs for the half year ended September…
- Innovana Thinklabs (Q2 FY27)
1,188.41 Lacs (~36.3% increase) . Key results statement takeaways from Innovana Thinklabs Ltd's Q2 FY27 results statement — and how it ranks against sector peer